AI Terminal

MODULE: AI_ANALYST
Interactive Q&A, Risk Assessment, Summarization
MODULE: DATA_EXTRACT
Excel Export, XBRL Parsing, Table Digitization
MODULE: PEER_COMP
Sector Benchmarking, Sentiment Analysis
SYSTEM ACCESS LOCKED
Authenticate / Register Log In

Melexis N.V.

Earnings Release Feb 10, 2016

3975_er_2016-02-10_763bdb01-59e2-40c1-8e18-6b7ee14217db.pdf

Earnings Release

Open in Viewer

Opens in native device viewer

Press release:

Melexis Q4 and FY 2015 results – Melexis sales exceed 400 million euro

Intermediate declaration by the Board of Directors

Ieper, Belgium – February 10th, 2016, 07.00 hrs CET

For the year 2015, sales were 400.1 million EUR, an increase of 20% compared to the previous year. The EUR/USD exchange rate evolution had a positive impact of 11% compared to 2014.

Gross margin was 192.1 million EUR, an increase of 19% compared to 2014.

R&D expenses were 14.2% of sales, G&A was at 4.8% of sales and Selling was at 2.2% of sales. The operating result was 107.6 million EUR, an increase of 21% compared to last year.

Net income was 99.1 million EUR, 2.45 EUR per share, an increase of 17% compared to 85.0 million EUR or 2.10 EUR per share in 2014.

Sales for the fourth quarter of 2015 were 102.4 million EUR, an increase of 16% compared to the same quarter of the previous year and an increase of 1% compared to the previous quarter.

The EUR/USD exchange rate evolution had a positive impact of 9% compared to the same quarter of last year and no impact compared to the previous quarter.

Gross margin was 47.5 million EUR, an increase of 8% compared to the same quarter of last year.

R&D expenses were 15.8% of sales, G&A was at 5.1% of sales and Selling was at 2.2% of sales. The operating result was 23.9 million EUR, an increase of 9% compared to the same quarter of the previous year.

Net income was 22.0 million EUR or 0.54 EUR per share, an increase of 9% compared to 20.2 million EUR or 0.50 EUR per share in the fourth quarter of 2014.

Dividend

The Board of Directors approved on February 8th 2016 to propose to the Annual Shareholder meeting to pay out over the result of 2015 a total dividend of EUR 1.90 gross per share. This amount contains an interim dividend of EUR 1.30 per share which was paid in October 2015 and a final dividend of EUR 0.60 per share which will be payable after approval of the Annual Shareholders meeting.

The Melexis shares will start trading ex coupon on April 26, 2016 (opening of the market). The record date is April 27, 2016 (closing of the market) and the dividend will be payable as from April 28, 2016.

Outlook

Melexis expects sales in the first quarter of 2016 to be around the level of 105 million EUR.

For full year 2016, Melexis expects sales growth to be between 8% and 12%, a gross profit margin around 47% and an operating margin around 25%, all taking into account a EUR/USD exchange rate of 1.10.

"With a year over year sales growth of more than 20%, a gross profit margin of 48% and an operating margin close to 27%, Melexis successfully accomplishes its 2015 full year guidance. We are extremely proud to achieve this result in a year which was, especially in the second half, marked by increased economic uncertainty resulting in cautious order behavior and inventory management by a number of customers. This performance clearly demonstrates that the Melexis product portfolio is able to address its customer challenges to build the car of the future: smart, safe, sustainable and stylish.

Sales in the fourth quarter increased slightly versus the third quarter, mainly due to a stronger USD currency versus the EUR. Also end of year order behavior was a touch stronger than anticipated. Melexis continues to invest in new equipment and research and development, confidently preparing the company for continued growth.

In line with the October announcement, we observe improved momentum in the beginning of 2016.

In 2015, the main contributors for growth were magnetic sensors and sensor interfaces. Other product lines outperforming company growth were wireless sensing, far infrared (FIR) and local interconnect network (LIN).

Sales to automotive customers represented 89% of total sales, both in the fourth quarter and full year 2015. The portion of standard product (ASSPs) sales represented 60% of total sales in the fourth quarter and 58% of sales for the full year 2015.''

Financial comment – Karen van Griensven, CFO

''The full year 2015 results demonstrated the ability of Melexis to combine an increased R&D spending with a record cash flow generation. We have confidence in the future. As a consequence, the Board of Directors proposed to pay out an additional final dividend to bring net cash in line with future business needs.''

Financial Calendar

  • Annual Shareholders Meeting: April 20, 2016
  • Publication Q1 2016 Results: April 22, 2016
  • Dividend pay date: April 28, 2016 (ex coupon on April 26, 2016)
  • Publication Q2/HY1 2016 Results: July 27, 2016
  • Publication Q3 2016 Results: October 26, 2016
  • Publication FY 2016 Results: February 8, 2017

The company's results will be discussed in a conference call on Wednesday, February 10th, 2016 at 17 hrs CET. The conference call will be in English. You have to register for this conference call in advance. You can register by clicking on the following link and filling out the requested information: https://eventreg1.conferencing.com/webportal3/reg.html?Acc=713722&Conf=194138 Conference ID: 957184.

After registration, you will receive the conference call number, a participant user pin, conference pin and instructions on how to join the conference call. For security purposes all participants must register individually if they wish to join the call.

A replay number for this call is available for 7 days after the end of the conference call. The replay number for this call is +32 2 290 17 05, access code: 954379.

For further information: Investor Relations Phone: +32 13 67 07 79 Fax: +32 13 67 21 34 Email: [email protected]

We Engineer The Sustainable Future Melexis Financial Press Release Regulated Information

Melexis NV (Euronext Brussels: MELE) is a mixed signal semiconductor manufacturer. Melexis designs, develops, tests and markets advanced integrated semiconductor devices for the automotive industry. Our core experience supplying ICs for automotive electronics sustains the expansion into Application Specific Standard Products for industrial and consumer product applications. Melexis enthusiastically pursues its role as a component supplier whose innovations are the essential element in nearly every one of our customers' extraordinary systems. At Melexis we engineer the sustainable future. Melexis' products include sensor, communication, actuator ICs and Application Specific Integrated Circuits (ASICs). Further information about Melexis can be found at http://www.melexis.com.

Disclaimer

Except for those statements that report the Company's historical results, the statements being made are forward looking statements. Actual results could differ materially from those projected in the forwardlooking statements. Factors which could cause actual results to differ from expectations include the following: volatility in supply and demand affecting revenues and market prices, price and availability of silicon foundry, assembly and test prices, assembly and test subcontract capacity required to meet financial targets and/or meet backlog requirements, risks and delays associated with bringing up new production capabilities or with deliveries from subcontractors, timing and market acceptance of new products, increased expenses associated with new product acceptance of new products, increased expenses associated with new product introductions of process changes, delays in developing or achieving volume production of new products, which can result in delays or failure to contribute to revenues and profits, ability of the Company to maintain its customer and vendor base and delays in and/or inability in raising additional capital.

Consolidated Income Statement

CONFORM IFRS Quarter ended Quarter ended Year ended Year ended
in k EUR 31/12/2015 31/12/2014 31/12/2015
audited
31/12/2014
audited
Sales 102,396 88,133 400,136 332,408
Cost of sales
Gross Margin
-54,904
47,492
-44,315
43,819
-208,015
192,121
-171,102
161,306
R&D
G&A
-16,136
-5,237
-12,805
-4,654
-56,737
-19,090
-45,434
-16,381
Selling
Other operating result
-2,216 -2,035
-2,340
-8,690 -7,976
-2,340
Operating result 23,904 21,984 107,604 89,175
Financial result
Income before taxes
249
24,154
1,099
23,083
1,869
109,473
2,908
92,083
Income taxes
Net income
-2,138
22,016
-2,843
20,240
-10,402
99,071
-7,089
84,994
Net income per share in EUR 0.54 0.50 2.45 2.10

Consolidated Statement of Financial Position

CONFORM IFRS Year ended Year ended
in k EUR 31/12/2015
audited
31/12/2014
audited
Current Assets :
Cash and cash equivalents 73,838 59,610
Current investments 49 17
A/R Trade 51,243 40,382
A/R from related parties 1,999 1,584
Advance related parties
Assets for current tax 1,384 978
Assets held for sale 289 1,210
Other current assets 5,237 5,911
Inventories 64,099 56,412
Total current assets 198,140 166,103
Non-current assets :
Costs of incorporation
Property, plant and equipment 90,300 71,733
Financial assets 6 6
Intangible fixed assets 7,440 4,723
A/R directors
Other non-current assets 8 964
Deferred tax assets 10,877 13,245
Total non current assets 108,630 90,671
Total assets 306,770 256,773

We Engineer The Sustainable Future 4

31/12/2015
31/12/2014
in k EUR
audited
audited
Liabilities and shareholders Equity
Current liabilities :
Bank loans and overdrafts
1,627
Derivative financial instruments
7,046
Current portion of LT debt
15,247
A/P trade
10,791
Affiliated companies
6,543
Accrued taxes
7,135
Accrued expenses and payroll
3,258
Other current liabilities
2,358
Deferred income
Total current liabilities
54,005
39,480
Non current liabilities :
8,138
LT debt less current portion
Deferred tax liabilities
2,116
Other non-current liabilities
Total non current liabilities
10,254
15,932
Shareholders' equity :
565
Shareholders' capital
Share premium
-3,818
Treasury shares
-372
Revaluation reserve Hedge
Revaluation reserve Fair value
57
Legal reserve
153,308
Retained earnings
99,071
Current period's profit
-6,311
Cumulative translation adjustment
242,500
Equity attributable to company owners
10
Non controlling interests
Total shareholders equity
242,511
201,361
Total liabilities, shareholders' equity
306,770
256,773
CONFORM IFRS Year ended Year ended
2,050
4,148
13,863
6,159
4,894
6,585
1,343
436
14,033
1,899
565
-3,818
-453
0
57
120,384
84,994
-379
201,351
10
and minority interests

Consolidated Statements of Cash Flow

CONFORM IFRS Year ended
31/12/2015
Year ended
31/12/2014
(in k EUR) audited audited
Cash flow from operating activities
Net income 99,071 84,994
Adjustments for :
Operating activities 26,017 21,167
Deferred taxes 2,368 851
Capital grants 806 677
Depreciation and amortisation 22,809 22,115
Unrealized exchange results 148 995
Financial result -114 -3,471
Operating profit before working capital changes 125,089 106,161
A/R, Trade -10,890 -1,957
A/R, affiliates -415 53
Other current assets -421 3,512
Other non current assets 956 484
Inventories -10,551 -15,225
A/P 1,342 -32
A/P affiliates 4,632 -1,302
Accrued expenses 6,505 6,903
Other current liabilities 1,727 95
Other non current liabilities 1,714 991
Interest paid -383 -412
Income tax -4,307 -4,276
Cash flow from operating activities 114,998 94,994
Cash flow from investing activities
Acquisition of subsidiary, net of cash acquired
Financial fixed assets
Purchase of PPE and intangible assets (netted) -40,281
Interest received 361
Investments/proceeds/ from current investments -33
(incl. financial instruments)
Cash provided from investing activities -39,953
Cash flows from financing activities -23,694
482
4,307
-18,905
Payment to acquire own shares
Proceeds/Repayment of long-and short-term debt -3,010
Proceeds/Repayment of bank loans and overdrafts
Proceeds from (repayment of) related party financing
Impact of exchange results on financing items -5,738
Dividend payment -52,070
Capital Decrease -4,146
-40,054
Non controlling interests
Cash provided from financing activities -60,818
-44,200
CTA 0 -487
Increase/decrease in cash and cash equivalents
Cash at beginning of the period
14,227
59,610
31,888
27,722

6

Sales per Geography

Q4/15 Q4/14 Q3/15 2015 2014
APAC
Asia Pacific
46% 47% 45% 46% 44%
EMEA
Europe - Middle-East - Africa
40% 39% 41% 40% 41%
NALA
North America - Latin America
14% 14% 14% 14% 15%
TOTAL 100% 100% 100% 100% 100%

Talk to a Data Expert

Have a question? We'll get back to you promptly.